RWML
VRTX icon

RAFFA WEALTH MANAGEMENT, LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.8K Buy
66
+4
+6% +$1.77K ﹤0.01% 215
2026
Q1 		$27.7K Buy
62
+1
+2% +$466 ﹤0.01% 222
2025
Q4 		$27.7K Buy
61
+8
+15% +$3.45K ﹤0.01% 225
2025
Q3 		$20.8K Buy
53
+4
+8% +$1.67K ﹤0.01% 260
2025
Q2 		$21.8K Sell
49
-4
-8% -$1.84K ﹤0.01% 261
2025
Q1 		$25.7K Hold
53
– – 0.01% 194
2024
Q4 		$21.3K Buy
53
+2
+4% +$927 0.01% 226
2024
Q3 		$23.7K Hold
51
– – 0.01% 204
2024
Q2 		$23.9K Hold
51
– – 0.01% 289
2024
Q1 		$21.3K Hold
51
– – 0.01% 297
2023
Q4 		$20.8K Hold
51
– – 0.01% 204
2023
Q3 		$17.7K Hold
51
– – 0.01% 207
2023
Q2 		$17.9K Hold
51
– – 0.01% 211
2023
Q1 		$16.1K Hold
51
– – 0.01% 236
2022
Q4 		$14.7K Buy
51
+1
+2% +$305 0.01% 236
2022
Q3 		$14.5K Hold
50
– – 0.01% 235
2022
Q2 		$14.1K Buy
50
+5
+11% +$1.34K 0.01% 251
2022
Q1 		$11.7K Hold
45
– – ﹤0.01% 272
2021
Q4 		$9.88K Hold
45
– – ﹤0.01% 306
2021
Q3 		$8.16K Sell
45
-4
-8% -$781 ﹤0.01% 286
2021
Q2 		$9.88K Buy
49
+1
+2% +$209 ﹤0.01% 267
2021
Q1 		$10.3K Buy
48
+7
+17% +$1.54K ﹤0.01% 274
2020
Q4 		$9.69K Sell
41
-2
-5% -$459 ﹤0.01% 254
2020
Q3 		$11.7K Hold
43
– – ﹤0.01% 224
2020
Q2 		$12.5K Buy
43
+5
+13% +$1.36K ﹤0.01% 207
2020
Q1 		$9.04K Buy
38
+21
+124% +$4.82K ﹤0.01% 214
2019
Q4 		$3.72K Hold
17
– – ﹤0.01% 306
2019
Q3 		$2.88K Buy
+17
New +$3.01K ﹤0.01% 328
2019
Q2 		– Sell
-17
Closed -$3.13K – 1383
2019
Q1 		$3.13K Hold
17
– – ﹤0.01% 287
2018
Q4 		$2.82K Hold
17
– – ﹤0.01% 307
2018
Q3 		$3.28K Hold
17
– – ﹤0.01% 310
2018
Q2 		$2.89K Hold
17
– – ﹤0.01% 314
2018
Q1 		$2.77K Buy
+17
New +$2.78K ﹤0.01% 303
2017
Q1 		– Sell
-7
Closed -$516 – 849
2016
Q4 		$516 Hold
7
– – ﹤0.01% 750
2016
Q3 		$610 Hold
7
– – ﹤0.01% 633
2016
Q2 		$602 Hold
7
– – ﹤0.01% 598
2016
Q1 		$556 Hold
7
– – ﹤0.01% 645
2015
Q4 		$881 Hold
7
– – ﹤0.01% 431
2015
Q3 		$729 Hold
7
– – ﹤0.01% 491
2015
Q2 		$864 Hold
7
– – ﹤0.01% 432
2015
Q1 		$826 Hold
7
– – ﹤0.01% 455
2014
Q4 		$832 Hold
7
– – ﹤0.01% 411
2014
Q3 		$786 Buy
+7
New +$666 ﹤0.01% 406
2014
Q1 		– Sell
-7
Closed -$832 – 727
2013
Q4 		$832 Buy
+7
New +$487 ﹤0.01% 411

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's VRTX Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its Vertex Pharmaceuticals (VRTX) stake by 6.5% in Q2 2026, buying an estimated $1.77K and bringing the position to 66 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #215.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in VRTX in Q4 2013 and has held it in 44 quarters since. 559 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 66 shares of Vertex Pharmaceuticals worth $32.8K as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC bought 4 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.77K.
  • Vertex Pharmaceuticals made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #215 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Vertex Pharmaceuticals in Q4 2013 and has held it in 44 quarters since.
  • 559 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.